Outlook Therapeutics Inc Stock Market Value
| OTLK Stock | USD 0.41 0.01 2.50% |
| Symbol | OUTLOOK |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.89) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
OUTLOOK THERAPEUTICS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OUTLOOK THERAPEUTICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OUTLOOK THERAPEUTICS.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in OUTLOOK THERAPEUTICS on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding OUTLOOK THERAPEUTICS INC or generate 0.0% return on investment in OUTLOOK THERAPEUTICS over 90 days. OUTLOOK THERAPEUTICS is related to or competes with Spruce Biosciences, NRX Pharmaceuticals, Cue Biopharma, Werewolf Therapeutics, IO Biotech, OS Therapies, and Coeptis Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing m... More
OUTLOOK THERAPEUTICS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OUTLOOK THERAPEUTICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OUTLOOK THERAPEUTICS INC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 72.05 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.32 |
OUTLOOK THERAPEUTICS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OUTLOOK THERAPEUTICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OUTLOOK THERAPEUTICS's standard deviation. In reality, there are many statistical measures that can use OUTLOOK THERAPEUTICS historical prices to predict the future OUTLOOK THERAPEUTICS's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.61) | |||
| Total Risk Alpha | (2.82) | |||
| Treynor Ratio | 1.88 |
OUTLOOK THERAPEUTICS February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | 1.89 | |||
| Mean Deviation | 5.62 | |||
| Coefficient Of Variation | (571.39) | |||
| Standard Deviation | 9.58 | |||
| Variance | 91.77 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (1.61) | |||
| Total Risk Alpha | (2.82) | |||
| Treynor Ratio | 1.88 | |||
| Maximum Drawdown | 72.05 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.32 | |||
| Skewness | (3.15) | |||
| Kurtosis | 18.11 |
OUTLOOK THERAPEUTICS INC Backtested Returns
OUTLOOK THERAPEUTICS INC maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18 % return per unit of standard deviation over the last 3 months. OUTLOOK THERAPEUTICS INC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OUTLOOK THERAPEUTICS's Market Risk Adjusted Performance of 1.89, risk adjusted performance of (0.13), and Coefficient Of Variation of (571.39) to confirm the risk estimate we provide. The company holds a Beta of -0.9, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning OUTLOOK THERAPEUTICS are expected to decrease slowly. On the other hand, during market turmoil, OUTLOOK THERAPEUTICS is expected to outperform it slightly. At this point, OUTLOOK THERAPEUTICS INC has a negative expected return of -1.79%. Please make sure to check OUTLOOK THERAPEUTICS's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if OUTLOOK THERAPEUTICS INC performance from the past will be repeated at some future point.
Auto-correlation | 0.41 |
Average predictability
OUTLOOK THERAPEUTICS INC has average predictability. Overlapping area represents the amount of predictability between OUTLOOK THERAPEUTICS time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OUTLOOK THERAPEUTICS INC price movement. The serial correlation of 0.41 indicates that just about 41.0% of current OUTLOOK THERAPEUTICS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.41 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out OUTLOOK THERAPEUTICS Correlation, OUTLOOK THERAPEUTICS Volatility and OUTLOOK THERAPEUTICS Performance module to complement your research on OUTLOOK THERAPEUTICS. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
OUTLOOK THERAPEUTICS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.